NovAccess Global Inc. (XSNX)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
-66.67%
Market Cap 6.19K
Revenue (ttm) n/a
Net Income (ttm) -2.66M
Shares Out 61.91M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 55,100
Average Volume 14,507
Open 0.0002
Previous Close 0.0001
Day's Range 0.0001 - 0.0002
52-Week Range 0.0000 - 0.0500
Beta 108.11
RSI 44.20
Earnings Date Feb 11, 2026

About NovAccess Global

NovAccess Global Inc., a biopharmaceutical company, engages in the development of novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in New York, New York. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol XSNX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.